Other tics of organic origin
ICD-10 G25.69 is a billable code used to indicate a diagnosis of other tics of organic origin.
G25.69 refers to tics that arise from identifiable organic causes, such as neurological disorders. These tics can manifest in various forms, including involuntary movements or vocalizations. In the context of Parkinson's disease and other extrapyramidal disorders, tics may occur due to the underlying pathophysiology of these conditions or as a side effect of dopaminergic medications used in treatment. Parkinson's disease, characterized by the degeneration of dopaminergic neurons in the substantia nigra, can lead to a range of movement disorders, including tremors, rigidity, and bradykinesia. The introduction of dopaminergic medications, while beneficial for managing symptoms, can sometimes exacerbate or induce tics. Extrapyramidal symptoms, which include a variety of movement disorders resulting from dysfunction in the basal ganglia, may also contribute to the development of tics. Accurate diagnosis and coding of G25.69 require a thorough understanding of the patient's medical history, medication regimen, and the specific nature of the tics observed.
Detailed neurological examination findings, medication history, and specific tic descriptions.
Patients with Parkinson's disease presenting with new-onset tics after medication adjustments.
Consideration of the patient's overall movement disorder and potential interactions with other medications.
Assessment of tic severity, impact on daily functioning, and any psychiatric comorbidities.
Patients with tic disorders exacerbated by anxiety or stress.
Differentiating between tic disorders and other psychiatric conditions.
Used for follow-up visits for patients with tics and movement disorders.
Detailed history, examination findings, and treatment plan.
Neurologists should document neurological assessments thoroughly.
Common causes include neurological disorders such as Parkinson's disease, Huntington's disease, and the effects of certain medications, particularly dopaminergic agents.
